Meeting
2023 ASCO Genitourinary Cancers Symposium
Is transrectal ultrasound or magnetic resonance imaging better at estimating prostatic volume for patients with prostate cancer?
Authors
Maxwell Sandberg
Wake Forest School of Medicine, Winston-Salem, NC
Maxwell Sandberg , Wyatt Whitman , Anita Rong , Ronald Davis III, Ashok Hemal , Matvey Tsivian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 314)
DOI
10.1200/JCO.2023.41.6_suppl.314
Abstract #
314
Poster Bd #
K14
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Prediction of pathological outcome at radical prostatectomy for MRI-ultrasound fusion prostate biopsy versus standard transrectal ultrasound guided prostate biopsy.
First Author: Hans Arora
Poster
2021 Genitourinary Cancers Symposium
MRI-guided fusion biopsy of the prostate resection bed among post-radical prostatectomy patients with rising PSA.
First Author: Cheyenne Williams
Poster
2017 Genitourinary Cancers Symposium
Cost-effectiveness analysis of magnetic resonance imaging-ultrasound fusion biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer.
First Author: Matthew Ingham
Poster
2015 Genitourinary Cancers Symposium
Comprehensive evaluation of the clinical utility of transperineal template guided mapping biopsy of prostate in the era of magnetic resonance imaging.
First Author: Arjun Sivaraman